La ricerca è una priorità per SIFaCT e la pubblicazione del paper su una rivista scientifica di livello internazionale è il risultato finale e tangibile del lavoro svolto. Di seguito le pubblicazioni vengono suddivise secondo diversi criteri per facilitare la selezione dell’articolo di interesse prodotto dalla società scientifica.
Nel riquadro a destra puoi selezionare i seguenti 4 filtri: Anno di pubblicazione – Primo autore – Impact factor – Topic
Survival with novel hormonal therapies in patients with nonmetastatic castration-resistant prostate cancer: indirect comparison of three randomized phase-III trials.
The “One-to-Many” Survival Analysis to Evaluate a New Treatment in Comparison With Therapeutic Alternatives Based on Reconstructed Patient Data: Enfortumab Vedotin Versus Standard of Care in Advanced or Metastatic Urothelial Carcinoma.
Application of artificial intelligence for an early comparison of efficacy between new cancer drugs
Chimeric Antigen Receptor T Cells in Large B-Cell Lymphoma: Analysis of Overall Survival Based on Reconstructed Patient-Level Data
Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments
Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression-free survival based on reconstructed individual patient data
First-line chemoimmunotherapy versus chemotherapy in PD-L1-negative patients with non-small-cell lung cancer
Age-Adjusted Survival Extrapolations-Results May Differ From Those Generated by the Weibull Model
Medical Therapy, Radiofrequency Ablation, or Cryoballoon Ablation as First-Line Treatment for Paroxysmal Atrial Fibrillation: Interpreting Efficacy Through the Shiny Method
Disposal practices for unused and expired medications: pilot data from three cities in three countries